Abbott Laboratories (ABT) 48.67 $ABT
SmarTrend Watching for Potential Pullback in Shares of Abbott Laboratories After 3.49% Gain
Comtex SmarTrend(R) - 1 hr 39 mins ago
Abbott Laboratories (NYSE:ABT) traded in a range yesterday that spanned from a low of $47.29 to a high of $48.79. Yesterday, the shares gained 3.5%, which took the trading range above the 3-day high of $47.74 on volume of 8.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ABT: 48.67 (+1.64)
World Sports and Fitness Nutrition Supplements Industry
PR Newswire - Tue May 12, 2:50PM CDT
This report analyzes the worldwide markets for Sports and Fitness Nutrition Supplements in US$ Thousands by the following Segments: Amino Acids/Derivatives, Herbal Products, Vitamins/Minerals, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 237 companies including many key and niche players such as -
ABT: 48.67 (+1.64)
API Market Strategic Analysis and Outlook 2015 - US Industry Supply, Demand, Infrastructure, Investment and Market Shares to 2019
M2 - Tue May 12, 12:20PM CDT
'API Market in the US 2015-2019', a report published by Market Research Store, has revealed that the API market in the US to grow at a CAGR of 7.01 percent over the period 2014-2019.
ABT: 48.67 (+1.64)
North American Ophthalmology Surgery Devices Market by Types, by End-users - Forecast to 2019 Out Now
M2 - Tue May 12, 9:39AM CDT
Research and Markets (http://www.researchandmarkets.com/research/fwhlhv/north_american) has announced the addition of the "North American Ophthalmology Surgery Devices Market by Types, by End-users - Forecast to 2019" report to their offering. The global ophthalmology glaucoma surgery devices market is estimated to grow at a CAGR of 8.4% from 2014 to 2019. The North American region accounted for the largest share of this market, and is projected to grow at a CAGR of 7.8% during the given forecast period. The ophthalmology glaucoma surgery device market holds a high potential for growth in the coming years owing to the increasing strategic expansion of companies, the growing aging population, and the rising incidence of eye disorders. However, general lack of awareness among people about eye disorders and poor primary healthcare infrastructure, along with lack of healthcare insurance, are the major factors that may restrain the growth of the global ophthalmology glaucoma surgery device market in the coming years. Geographically, the market has been segmented into North America, Europe, Asia, and Rest of the World (RoW), wherein the North American market commanded the largest share of 45.1% of the global ophthalmology glaucoma surgery device market in 2014, followed by the European market. The report has profiled the leading players of this market, along with the developments (new product launches, partnerships, agreements, collaborations, and joint ventures) done by the companies over the past few years and strategies adopted by them to sustain and strengthen their positions in the global ophthalmology glaucoma surgery device market. Companies Mentioned: - Abbott Laboratories - Alcon, Inc. - Allergan, Inc. - Baush & Lomb, Inc. - Carl Zeiss Meditec Ag - Essilor Internationals S.A. - Nidek Co., Limited - Staar Surgical Company - Topcon Corporation For more information visit http://www.researchandmarkets.com/research/fw...h_american About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
AGN: 240.22 (+2.88), ABT: 48.67 (+1.64), STAA: 9.49 (+0.39)
5 Largest Markets for Pharmaceuticals
Cheryl Swanson, The Motley Fool - Motley Fool - Tue May 12, 9:26AM CDT
Source: Flickr, Creative Commons. If you're a biotech or Big Pharma company, your world is not only growing, it's standing on its head. According to the Institute for Healthcare Informatics, worldwide spending for prescription branded drugs and...
ABT: 48.67 (+1.64), PFE: 33.94 (+0.41), AMGN: 161.98 (+3.59), LLY: 73.06 (+0.26), BMY: 67.45 (+0.05), GSK: 44.99 (+0.46), JNJ: 101.83 (+1.28), GILD: 108.74 (+2.35), MRK: 59.78 (+0.60), ABBV: 65.97 (+0.67), NVS: 103.90 (+1.23)
Regeneron, Nike Top Big Cap 20 Stocks Near Buy Points
at Investor's Business Daily - Mon May 11, 6:16PM CDT
A handful of Big Cap 20 stocks are hovering near buy points. Regeneron Pharmaceuticals (REGN) is trying to clear a 486.10 buy point of a cup-with-handle base. The pattern is late-stage, which makes it risky. Profit and revenue growth have picked up...
ABT: 48.67 (+1.64), ANTM: 160.00 (+1.21), NKE: 103.44 (+1.28), ABBV: 65.97 (+0.67), REGN: 491.43 (+13.97)
Abbott Laboratories Rises 2.30% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Fri May 08, 4:55PM CDT
Abbott Laboratories (NYSE:ABT) traded in a range yesterday that spanned from a low of $47.03 to a high of $47.70. Yesterday, the shares gained 2.3%, which took the trading range above the 3-day high of $47.21 on volume of 4.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ABT: 48.67 (+1.64)
California Supreme Court says no to pharma's pay-for-delay deals
Seeking Alpha - at Seeking Alpha - Thu May 07, 4:30PM CDT
ABT: 48.67 (+1.64), TEVA: 61.22 (+0.12), ABBV: 65.97 (+0.67)
FDA to hold public meeting on off-label drug promotion
Seeking Alpha - at Seeking Alpha - Thu May 07, 10:13AM CDT
ABT: 48.67 (+1.64), BIB: 167.99 (+4.16), PFE: 33.94 (+0.41), IBB: 355.59 (+4.74), DRGS: 60.89 (unch), LLY: 73.06 (+0.26), BMY: 67.45 (+0.05), GSK: 44.99 (+0.46), JNJ: 101.83 (+1.28), BIS: 31.42 (-0.83), AZN: 70.10 (+0.75), MRK: 59.78 (+0.60), ABBV: 65.97 (+0.67), SNY: 50.79 (+0.90), IRY: 53.79 (+0.78), IXJ: 110.55 (+1.56), NVS: 103.90 (+1.23)
Global Molecular Diagnostics in Infectious Disease Testing Market 2015
M2 - Thu May 07, 6:53AM CDT
Research and Markets (http://www.researchandmarkets.com/research/l4xc2p/molecular) has announced the addition of the "Molecular Diagnostics in Infectious Disease Testing" report to their offering. This report describes the specific segment of the in vitro diagnostics market known as molecular diagnostics testing for infectious disease. In the current medical diagnostics market, molecular diagnostics in infectious disease testing offers one of the most promising areas for growth and innovation. The confluence of breakthroughs in genomics and proteomics - along with the development of microarray devices to measure analytes in the blood - has led to this revolutionary market development. Specifically, molecular diagnostics offers the power of advanced analytical techniques to diagnose infectious diseases. Whereas before, the detection of many infectious agents was slow and expensive due to reliance upon culturing methods, researchers are now at the cusp of overcoming such limitations via the use of nucleic acid-mediated molecular diagnostics testing. The purpose of this report is to describe the emerging field of molecular diagnostics in infectious disease testing. The infectious disease space is the most dominant and profitable sector of molecular diagnostics. Topics covered in this study include: - The existing and emerging technologies in the field - The U.S. and global market size for molecular diagnostic products - The profiles of companies that are focusing on the molecular diagnostic sector. The research examines drivers and restraints for sales growth, market share and technical trends. In addition, an in-depth analysis of the competitive situation of prominent market venders is provided with five-year sales forecasts. Key Topics Covered: 1. Overview 2. Introduction to Molecular Diagnostics for Infectious Disease Testing 3. Infectious Disease Diagnostics Molecular Testing Market 4. Molecular Diagnostic Testing Technology for Infectious Disease Testing 5. Business 6. Reimbursement and Billing Landscape for Molecular Diagnostics Testing for Infectious Disease 7. Regulatory Requirements 8. Business Decisions using Molecular Diagnostic Tests in Infectious Disease Testing 9. Economics of Anti-Microbial Drug Resistance: The Persistent Need for Antibacterials 10. Company Profiles - Abbott Laboratories - Affymetrix - Arcxis Biotechnologies - Asuragen, Inc. - AutoGenomics, Inc. - Becton, Dickinson and Company - bioM?rieux - Biocartis - BioHelix Corporation (now part of Quidel) - bioTheranostics - Cepheid - EraGen Biosciences - GenMark Diagnostics, Inc. - Genomix Biotech - Gen-Probe, Inc. (now known as Hologic Gen-Probe) - Great Basin Corporation - Illumina, Inc. - Life Technologies (Thermo Fisher Scientific) - Luminex Corp. - Mobidiag - Myconostica - Myriad Genetics, Inc. - Nanosphere - NorDiag ASA (The DiaSorin Group) - Qiagen N.V. - Quidel - Roche Diagnostics (Roche Ltd.) - SACACE - Seegene - Siemens AG - SIRS-Lab - TrimGen - TrovaGene - Veredus Laboratories - Veridex, LLC For more information visit http://www.researchandmarkets.com/research/l4xc2p/molecular
GNMK: 9.42 (+0.05), LIFE: 20.58 (+0.99), ABT: 48.67 (+1.64), MYGN: 34.16 (+0.09), AGMX: (), CPHD: 58.10 (+0.44), ILMN: 198.92 (+0.69), QGEN: 24.50 (+0.05), LMNX: 16.72 (-0.10)
Global Sports and Fitness Nutrition Foods and Drinks Industry
PR Newswire - Wed May 06, 2:53PM CDT
This report analyzes the worldwide markets for Sports and Fitness Nutrition Foods and Drinks in US$ Thousands by the following Segments: Sports/Energy Foods, and Sports/Energy Drinks. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 219 companies including many key and niche players such as -
ABT: 48.67 (+1.64)
Next Support Level for Abbott Laboratories (ABT) is $46.52
Comtex SmarTrend(R) - Wed May 06, 9:40AM CDT
Abbott Laboratories (NYSE:ABT) has opened bearishly below the pivot of $46.95 today and has reached the first level of support at $46.68. Analysts will be watching for a cross of the next downside pivot targets of $46.52 and $46.09.
ABT: 48.67 (+1.64)
New CEO takes over evolving drugmaker Bristol-Myers Squibb
By LINDA A. JOHNSON - AP - Tue May 05, 2:25PM CDT
TRENTON, N.J. (AP) — Drugmaker Bristol-Myers Squibb Co. has a new leader, Dr. Giovanni Caforio, who became CEO as the company's annual meeting in Plainsboro, New Jersey, ended Tuesday.
ABT: 48.67 (+1.64), BMY: 67.45 (+0.05)
Health Care Equipment Equities Technical Study -- Boston Scientific, Abbott Laboratories, Accuray, Zimmer Holdings, and Amedica
PR Newswire - Tue May 05, 7:30AM CDT
Editor Note: For more information about this release, please scroll to bottom.
ZMH: 113.57 (+1.73), BSX: 17.91 (+0.68), ABT: 48.67 (+1.64), ARAY: 6.08 (-0.11), AMDA: 0.22 (-0.01)
Transplant Diagnostics Market by Technology, Antigen, Product, Application, End User - Global Forecasts to 2019
M2 - Tue May 05, 6:48AM CDT
Research and Markets (http://www.researchandmarkets.com/research/4ndmll/transplant) has announced the addition of the "Transplant Diagnostics Market by Technology (Serological, MLC, PCR, NGS), Antigen (HLA Class I & II), Product (Instrument, Reagent, Kits), Application (Diagnostic, Research), End User (Hospitals, Diagnostic Centers, Academia) - Global Forecasts to 2019" report to their offering. The global transplant diagnostics market is poised to grow at a CAGR of 6.5% during 2014-2019, and is expected to reach a value of $645.0 Million in 2019. A number of factors such as growing geriatric population, coupled with an increasing population base for chronic disease patients, technological advancement in the field of HLA typing, increased public-private investments to develop innovative HLA testing products, rising number of solid organ, soft tissue, and stem cell-based transplantation procedures across the world are propelling the growth of global transplant diagnostics market. However, factors such as high cost of PCR and NGS instruments and limited medical reimbursement available for transplantation procedures across the globe are restraining the growth of this market. Huge gap between organs donated and organ transplantation required annually is negatively affecting the growth of this market. New product launches and product developments are the key strategies adopted by the major players to develop their position in this global market. Moreover, strategies such as geographic expansions, partnerships, agreements, collaborations, and acquisitions were also adopted by a significant number of market players to strengthen their product portfolio and to expand their geographic presence in the transplant diagnostics market. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Insights 7 Transplant Diagnostics Market, By Technology 8 Transplant Diagnostics Market, By Product and Services 9 Transplant Diagnostics Market, By End User 10 Transplant Diagnostics Market, By Application 11 Transplant Diagnostics Market, By Region 12 Competitive Landscape 13 Compny Profiles - Abbott Laboratories, Inc. - Bio-Rad Laboratories , Inc. - F. Hoffmann-LA Roche Ltd. - Illumina, Inc. - Immucor, Inc. - Linkage Biosciences - Olerup SSP AB - Qiagen N.V. - Sigma-Aldrich - Thermo Fisher Scientific Inc. For more information visit http://www.researchandmarkets.com/research/4ndmll/transplant
ABT: 48.67 (+1.64), ILMN: 198.92 (+0.69), QGEN: 24.50 (+0.05)
Global Home Healthcare Global Market 2015 - Forecast to 2020
M2 - Tue May 05, 6:11AM CDT
Research and Markets (http://www.researchandmarkets.com/research/z6x9rd/home_healthcare) has announced the addition of the "Home Healthcare Global Market - Forecast to 2020" report to their offering. Global home healthcare market is expected to reach more than $300 billion growing at a CAGR of around 8.0% The home healthcare equipment market is expected to grow at a faster rate compared to home healthcare services market. Home healthcare is gaining a tremendous attention over hospitals for the sophistication, ease and privacy of treatment it offers. Increased in-hospital care cost, comfort of recovering at home and enhanced age-related chronic diseases in developing as well as developed countries are factors driving the overall growth of home healthcare market. Whereas factors such as poor technology adoption, weak reimbursement policies and rapidly changing technologies are hampering the market growth. Moreover, high capital costs, medical equipment, human resources and conventional model of business are the challenges faced by home healthcare market. The opportunities increasing the market trend is attributed to medical insurance by governments or organizations and cost-effectiveness.North America adopting novel technologies and portable diagnostic devices accounts for the largest share in the home healthcare market. While Europe with the presence of well-equipped healthcare reimbursement structure is the second leading market. Asia-Pacific is expected to grow at the highest CAGR driven by the aging population in countries such as India, China, and Japan. The major players operating in the home healthcare market include Johnson and Johnson (U.S.), Braun (Germany), GE Healthcare (U.K.), Baxter International (U.S.), Philips Healthcare (Netherlands), Medtronic (U.S.), Abbott Laboratories (U.S.), Invacare (U.S.) and others. Key Topics Covered: 1. Executive Summary 2. Introduction 3. Market Analysis 4. Home Healthcare Therapeutic Equipment Market 5. Home Healthcare Services Market 6. Home Healthcare Telehealth Market 7. Regional Market Analysis 8. Company Developments 9. Major Company Profiles - Abbott Laboratories - Baxter International - Braun - Novo Nordisk - GE Healthcare - Invacare - Johnson and Johnson - Medtronic - Philips Healthcare - Roche Holding AG For more information visit http://www.researchandmarkets.com/research/z6...healthcare
JNJ: 101.83 (+1.28), ABT: 48.67 (+1.64), NVO: 56.69 (+0.87), MDT: 76.26 (+1.40), IVC: 20.51 (+0.51), BAX: 69.04 (+0.94)
Sports and Fitness Nutrition Foods and Drinks - Global Strategic Business Report 2015-2020: Demand for Natural Energy Enhancing Ingredients Witness an Upward Trend
M2 - Tue May 05, 5:10AM CDT
Research and Markets (http://www.researchandmarkets.com/research/4fbw8q/sports_and) has announced the addition of the "Sports and Fitness Nutrition Foods and Drinks - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Sports and Fitness Nutrition Foods and Drinks in US$ Thousands by the following Segments: Sports/Energy Foods, and Sports/Energy Drinks. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 219 companies including many key and niche players such as: - Abbott Laboratories Inc. (USA) - Clif Bar & Company (USA) - Coca-Cola Co. (USA) - Dr Pepper Snapple Group, Inc. (USA) - Glanbia Plc (Ireland) - Glanbia Nutritionals Limited (UK) - Optimum Nutrition Inc. (USA) - GlaxoSmithKline Plc (UK) - GNC Holdings, Inc. (USA) - Lucozade Ribena Suntory Ltd. (UK) - Monster Beverage Corporation (USA) - Nestl? SA (Switzerland) - Otsuka Pharmaceutical Co., Ltd. (Japan) - PepsiCo Inc. (USA) - The Quaker Oats Company, Inc. (USA) - Post Holdings, Inc. (US) - Red Bull GmbH (Austria) - Rockstar Inc. (USA) - The Balance Bar Company (USA) - Yakult Honsha Co., Ltd. (Japan) Key Topics Covered: 1. INDUSTRY OVERVIEW 2. TRENDS, DRIVERS AND ISSUES 3. PRODUCT OVERVIEW 4. PRODUCT INNOVATIONS/INTRODUCTIONS 5. RECENT INDUSTRY ACTIVITY 6. FOCUS ON SELECT GLOBAL PLAYERS 7. GLOBAL MARKET PERSPECTIVE Total Companies Profiled: 219 (including Divisions/Subsidiaries 237) - The United States (130) - Canada (6) - Japan (5) - Europe (52) - - France (7) - - Germany (2) - - The United Kingdom (32) - - Rest of Europe (11) - Asia-Pacific (Excluding Japan) (33) - Latin America (6) - Africa (5) For more information visit http://www.researchandmarkets.com/research/4fbw8q/sports_and
KO: 41.50 (+0.45), POST: 44.63 (-0.28), MNST: 132.64 (+2.70), ABT: 48.67 (+1.64), GSK: 44.99 (+0.46), PEP: 98.00 (+1.59)
India Coronary Stent Market to be Tripled by 2021
PR Newswire Europe - Tue May 05, 3:25AM CDT
No one has covered cath labs in India like us: ABMRG
BSX: 17.91 (+0.68), ABT: 48.67 (+1.64), MDT: 76.26 (+1.40)
Can Mylan (MYL) Specialty Segment Secure Earnings Beat? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon May 04, 3:00PM CDT
Mylan (MYL) is set to report first-quarter 2015 results on May 5 after market closes.
ABT: 48.67 (+1.64), ACT: 297.46 (+1.77), PRGO: 194.15 (+0.36), MYL: 71.53 (+0.68)
SmarTrend Watching for Potential Pullback in Shares of Abbott Laboratories After 3.49% Gain
Comtex SmarTrend(R) - 1 hr 39 mins ago
Abbott Laboratories (NYSE:ABT) traded in a range yesterday that spanned from a low of $47.29 to a high of $48.79. Yesterday, the shares gained 3.5%, which took the trading range above the 3-day high of $47.74 on volume of 8.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ABT: 48.67 (+1.64)
World Sports and Fitness Nutrition Supplements Industry
PR Newswire - Tue May 12, 2:50PM CDT
This report analyzes the worldwide markets for Sports and Fitness Nutrition Supplements in US$ Thousands by the following Segments: Amino Acids/Derivatives, Herbal Products, Vitamins/Minerals, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 237 companies including many key and niche players such as -
ABT: 48.67 (+1.64)
API Market Strategic Analysis and Outlook 2015 - US Industry Supply, Demand, Infrastructure, Investment and Market Shares to 2019
M2 - Tue May 12, 12:20PM CDT
'API Market in the US 2015-2019', a report published by Market Research Store, has revealed that the API market in the US to grow at a CAGR of 7.01 percent over the period 2014-2019.
ABT: 48.67 (+1.64)
North American Ophthalmology Surgery Devices Market by Types, by End-users - Forecast to 2019 Out Now
M2 - Tue May 12, 9:39AM CDT
Research and Markets (http://www.researchandmarkets.com/research/fwhlhv/north_american) has announced the addition of the "North American Ophthalmology Surgery Devices Market by Types, by End-users - Forecast to 2019" report to their offering. The global ophthalmology glaucoma surgery devices market is estimated to grow at a CAGR of 8.4% from 2014 to 2019. The North American region accounted for the largest share of this market, and is projected to grow at a CAGR of 7.8% during the given forecast period. The ophthalmology glaucoma surgery device market holds a high potential for growth in the coming years owing to the increasing strategic expansion of companies, the growing aging population, and the rising incidence of eye disorders. However, general lack of awareness among people about eye disorders and poor primary healthcare infrastructure, along with lack of healthcare insurance, are the major factors that may restrain the growth of the global ophthalmology glaucoma surgery device market in the coming years. Geographically, the market has been segmented into North America, Europe, Asia, and Rest of the World (RoW), wherein the North American market commanded the largest share of 45.1% of the global ophthalmology glaucoma surgery device market in 2014, followed by the European market. The report has profiled the leading players of this market, along with the developments (new product launches, partnerships, agreements, collaborations, and joint ventures) done by the companies over the past few years and strategies adopted by them to sustain and strengthen their positions in the global ophthalmology glaucoma surgery device market. Companies Mentioned: - Abbott Laboratories - Alcon, Inc. - Allergan, Inc. - Baush & Lomb, Inc. - Carl Zeiss Meditec Ag - Essilor Internationals S.A. - Nidek Co., Limited - Staar Surgical Company - Topcon Corporation For more information visit http://www.researchandmarkets.com/research/fw...h_american About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
AGN: 240.22 (+2.88), ABT: 48.67 (+1.64), STAA: 9.49 (+0.39)
5 Largest Markets for Pharmaceuticals
Cheryl Swanson, The Motley Fool - Motley Fool - Tue May 12, 9:26AM CDT
Source: Flickr, Creative Commons. If you're a biotech or Big Pharma company, your world is not only growing, it's standing on its head. According to the Institute for Healthcare Informatics, worldwide spending for prescription branded drugs and...
ABT: 48.67 (+1.64), PFE: 33.94 (+0.41), AMGN: 161.98 (+3.59), LLY: 73.06 (+0.26), BMY: 67.45 (+0.05), GSK: 44.99 (+0.46), JNJ: 101.83 (+1.28), GILD: 108.74 (+2.35), MRK: 59.78 (+0.60), ABBV: 65.97 (+0.67), NVS: 103.90 (+1.23)
Regeneron, Nike Top Big Cap 20 Stocks Near Buy Points
at Investor's Business Daily - Mon May 11, 6:16PM CDT
A handful of Big Cap 20 stocks are hovering near buy points. Regeneron Pharmaceuticals (REGN) is trying to clear a 486.10 buy point of a cup-with-handle base. The pattern is late-stage, which makes it risky. Profit and revenue growth have picked up...
ABT: 48.67 (+1.64), ANTM: 160.00 (+1.21), NKE: 103.44 (+1.28), ABBV: 65.97 (+0.67), REGN: 491.43 (+13.97)
Abbott Laboratories Rises 2.30% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Fri May 08, 4:55PM CDT
Abbott Laboratories (NYSE:ABT) traded in a range yesterday that spanned from a low of $47.03 to a high of $47.70. Yesterday, the shares gained 2.3%, which took the trading range above the 3-day high of $47.21 on volume of 4.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ABT: 48.67 (+1.64)
California Supreme Court says no to pharma's pay-for-delay deals
Seeking Alpha - at Seeking Alpha - Thu May 07, 4:30PM CDT
ABT: 48.67 (+1.64), TEVA: 61.22 (+0.12), ABBV: 65.97 (+0.67)
FDA to hold public meeting on off-label drug promotion
Seeking Alpha - at Seeking Alpha - Thu May 07, 10:13AM CDT
ABT: 48.67 (+1.64), BIB: 167.99 (+4.16), PFE: 33.94 (+0.41), IBB: 355.59 (+4.74), DRGS: 60.89 (unch), LLY: 73.06 (+0.26), BMY: 67.45 (+0.05), GSK: 44.99 (+0.46), JNJ: 101.83 (+1.28), BIS: 31.42 (-0.83), AZN: 70.10 (+0.75), MRK: 59.78 (+0.60), ABBV: 65.97 (+0.67), SNY: 50.79 (+0.90), IRY: 53.79 (+0.78), IXJ: 110.55 (+1.56), NVS: 103.90 (+1.23)
Global Molecular Diagnostics in Infectious Disease Testing Market 2015
M2 - Thu May 07, 6:53AM CDT
Research and Markets (http://www.researchandmarkets.com/research/l4xc2p/molecular) has announced the addition of the "Molecular Diagnostics in Infectious Disease Testing" report to their offering. This report describes the specific segment of the in vitro diagnostics market known as molecular diagnostics testing for infectious disease. In the current medical diagnostics market, molecular diagnostics in infectious disease testing offers one of the most promising areas for growth and innovation. The confluence of breakthroughs in genomics and proteomics - along with the development of microarray devices to measure analytes in the blood - has led to this revolutionary market development. Specifically, molecular diagnostics offers the power of advanced analytical techniques to diagnose infectious diseases. Whereas before, the detection of many infectious agents was slow and expensive due to reliance upon culturing methods, researchers are now at the cusp of overcoming such limitations via the use of nucleic acid-mediated molecular diagnostics testing. The purpose of this report is to describe the emerging field of molecular diagnostics in infectious disease testing. The infectious disease space is the most dominant and profitable sector of molecular diagnostics. Topics covered in this study include: - The existing and emerging technologies in the field - The U.S. and global market size for molecular diagnostic products - The profiles of companies that are focusing on the molecular diagnostic sector. The research examines drivers and restraints for sales growth, market share and technical trends. In addition, an in-depth analysis of the competitive situation of prominent market venders is provided with five-year sales forecasts. Key Topics Covered: 1. Overview 2. Introduction to Molecular Diagnostics for Infectious Disease Testing 3. Infectious Disease Diagnostics Molecular Testing Market 4. Molecular Diagnostic Testing Technology for Infectious Disease Testing 5. Business 6. Reimbursement and Billing Landscape for Molecular Diagnostics Testing for Infectious Disease 7. Regulatory Requirements 8. Business Decisions using Molecular Diagnostic Tests in Infectious Disease Testing 9. Economics of Anti-Microbial Drug Resistance: The Persistent Need for Antibacterials 10. Company Profiles - Abbott Laboratories - Affymetrix - Arcxis Biotechnologies - Asuragen, Inc. - AutoGenomics, Inc. - Becton, Dickinson and Company - bioM?rieux - Biocartis - BioHelix Corporation (now part of Quidel) - bioTheranostics - Cepheid - EraGen Biosciences - GenMark Diagnostics, Inc. - Genomix Biotech - Gen-Probe, Inc. (now known as Hologic Gen-Probe) - Great Basin Corporation - Illumina, Inc. - Life Technologies (Thermo Fisher Scientific) - Luminex Corp. - Mobidiag - Myconostica - Myriad Genetics, Inc. - Nanosphere - NorDiag ASA (The DiaSorin Group) - Qiagen N.V. - Quidel - Roche Diagnostics (Roche Ltd.) - SACACE - Seegene - Siemens AG - SIRS-Lab - TrimGen - TrovaGene - Veredus Laboratories - Veridex, LLC For more information visit http://www.researchandmarkets.com/research/l4xc2p/molecular
GNMK: 9.42 (+0.05), LIFE: 20.58 (+0.99), ABT: 48.67 (+1.64), MYGN: 34.16 (+0.09), AGMX: (), CPHD: 58.10 (+0.44), ILMN: 198.92 (+0.69), QGEN: 24.50 (+0.05), LMNX: 16.72 (-0.10)
Global Sports and Fitness Nutrition Foods and Drinks Industry
PR Newswire - Wed May 06, 2:53PM CDT
This report analyzes the worldwide markets for Sports and Fitness Nutrition Foods and Drinks in US$ Thousands by the following Segments: Sports/Energy Foods, and Sports/Energy Drinks. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 219 companies including many key and niche players such as -
ABT: 48.67 (+1.64)
Next Support Level for Abbott Laboratories (ABT) is $46.52
Comtex SmarTrend(R) - Wed May 06, 9:40AM CDT
Abbott Laboratories (NYSE:ABT) has opened bearishly below the pivot of $46.95 today and has reached the first level of support at $46.68. Analysts will be watching for a cross of the next downside pivot targets of $46.52 and $46.09.
ABT: 48.67 (+1.64)
New CEO takes over evolving drugmaker Bristol-Myers Squibb
By LINDA A. JOHNSON - AP - Tue May 05, 2:25PM CDT
TRENTON, N.J. (AP) — Drugmaker Bristol-Myers Squibb Co. has a new leader, Dr. Giovanni Caforio, who became CEO as the company's annual meeting in Plainsboro, New Jersey, ended Tuesday.
ABT: 48.67 (+1.64), BMY: 67.45 (+0.05)
Health Care Equipment Equities Technical Study -- Boston Scientific, Abbott Laboratories, Accuray, Zimmer Holdings, and Amedica
PR Newswire - Tue May 05, 7:30AM CDT
Editor Note: For more information about this release, please scroll to bottom.
ZMH: 113.57 (+1.73), BSX: 17.91 (+0.68), ABT: 48.67 (+1.64), ARAY: 6.08 (-0.11), AMDA: 0.22 (-0.01)
Transplant Diagnostics Market by Technology, Antigen, Product, Application, End User - Global Forecasts to 2019
M2 - Tue May 05, 6:48AM CDT
Research and Markets (http://www.researchandmarkets.com/research/4ndmll/transplant) has announced the addition of the "Transplant Diagnostics Market by Technology (Serological, MLC, PCR, NGS), Antigen (HLA Class I & II), Product (Instrument, Reagent, Kits), Application (Diagnostic, Research), End User (Hospitals, Diagnostic Centers, Academia) - Global Forecasts to 2019" report to their offering. The global transplant diagnostics market is poised to grow at a CAGR of 6.5% during 2014-2019, and is expected to reach a value of $645.0 Million in 2019. A number of factors such as growing geriatric population, coupled with an increasing population base for chronic disease patients, technological advancement in the field of HLA typing, increased public-private investments to develop innovative HLA testing products, rising number of solid organ, soft tissue, and stem cell-based transplantation procedures across the world are propelling the growth of global transplant diagnostics market. However, factors such as high cost of PCR and NGS instruments and limited medical reimbursement available for transplantation procedures across the globe are restraining the growth of this market. Huge gap between organs donated and organ transplantation required annually is negatively affecting the growth of this market. New product launches and product developments are the key strategies adopted by the major players to develop their position in this global market. Moreover, strategies such as geographic expansions, partnerships, agreements, collaborations, and acquisitions were also adopted by a significant number of market players to strengthen their product portfolio and to expand their geographic presence in the transplant diagnostics market. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Insights 7 Transplant Diagnostics Market, By Technology 8 Transplant Diagnostics Market, By Product and Services 9 Transplant Diagnostics Market, By End User 10 Transplant Diagnostics Market, By Application 11 Transplant Diagnostics Market, By Region 12 Competitive Landscape 13 Compny Profiles - Abbott Laboratories, Inc. - Bio-Rad Laboratories , Inc. - F. Hoffmann-LA Roche Ltd. - Illumina, Inc. - Immucor, Inc. - Linkage Biosciences - Olerup SSP AB - Qiagen N.V. - Sigma-Aldrich - Thermo Fisher Scientific Inc. For more information visit http://www.researchandmarkets.com/research/4ndmll/transplant
ABT: 48.67 (+1.64), ILMN: 198.92 (+0.69), QGEN: 24.50 (+0.05)
Global Home Healthcare Global Market 2015 - Forecast to 2020
M2 - Tue May 05, 6:11AM CDT
Research and Markets (http://www.researchandmarkets.com/research/z6x9rd/home_healthcare) has announced the addition of the "Home Healthcare Global Market - Forecast to 2020" report to their offering. Global home healthcare market is expected to reach more than $300 billion growing at a CAGR of around 8.0% The home healthcare equipment market is expected to grow at a faster rate compared to home healthcare services market. Home healthcare is gaining a tremendous attention over hospitals for the sophistication, ease and privacy of treatment it offers. Increased in-hospital care cost, comfort of recovering at home and enhanced age-related chronic diseases in developing as well as developed countries are factors driving the overall growth of home healthcare market. Whereas factors such as poor technology adoption, weak reimbursement policies and rapidly changing technologies are hampering the market growth. Moreover, high capital costs, medical equipment, human resources and conventional model of business are the challenges faced by home healthcare market. The opportunities increasing the market trend is attributed to medical insurance by governments or organizations and cost-effectiveness.North America adopting novel technologies and portable diagnostic devices accounts for the largest share in the home healthcare market. While Europe with the presence of well-equipped healthcare reimbursement structure is the second leading market. Asia-Pacific is expected to grow at the highest CAGR driven by the aging population in countries such as India, China, and Japan. The major players operating in the home healthcare market include Johnson and Johnson (U.S.), Braun (Germany), GE Healthcare (U.K.), Baxter International (U.S.), Philips Healthcare (Netherlands), Medtronic (U.S.), Abbott Laboratories (U.S.), Invacare (U.S.) and others. Key Topics Covered: 1. Executive Summary 2. Introduction 3. Market Analysis 4. Home Healthcare Therapeutic Equipment Market 5. Home Healthcare Services Market 6. Home Healthcare Telehealth Market 7. Regional Market Analysis 8. Company Developments 9. Major Company Profiles - Abbott Laboratories - Baxter International - Braun - Novo Nordisk - GE Healthcare - Invacare - Johnson and Johnson - Medtronic - Philips Healthcare - Roche Holding AG For more information visit http://www.researchandmarkets.com/research/z6...healthcare
JNJ: 101.83 (+1.28), ABT: 48.67 (+1.64), NVO: 56.69 (+0.87), MDT: 76.26 (+1.40), IVC: 20.51 (+0.51), BAX: 69.04 (+0.94)
Sports and Fitness Nutrition Foods and Drinks - Global Strategic Business Report 2015-2020: Demand for Natural Energy Enhancing Ingredients Witness an Upward Trend
M2 - Tue May 05, 5:10AM CDT
Research and Markets (http://www.researchandmarkets.com/research/4fbw8q/sports_and) has announced the addition of the "Sports and Fitness Nutrition Foods and Drinks - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Sports and Fitness Nutrition Foods and Drinks in US$ Thousands by the following Segments: Sports/Energy Foods, and Sports/Energy Drinks. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 219 companies including many key and niche players such as: - Abbott Laboratories Inc. (USA) - Clif Bar & Company (USA) - Coca-Cola Co. (USA) - Dr Pepper Snapple Group, Inc. (USA) - Glanbia Plc (Ireland) - Glanbia Nutritionals Limited (UK) - Optimum Nutrition Inc. (USA) - GlaxoSmithKline Plc (UK) - GNC Holdings, Inc. (USA) - Lucozade Ribena Suntory Ltd. (UK) - Monster Beverage Corporation (USA) - Nestl? SA (Switzerland) - Otsuka Pharmaceutical Co., Ltd. (Japan) - PepsiCo Inc. (USA) - The Quaker Oats Company, Inc. (USA) - Post Holdings, Inc. (US) - Red Bull GmbH (Austria) - Rockstar Inc. (USA) - The Balance Bar Company (USA) - Yakult Honsha Co., Ltd. (Japan) Key Topics Covered: 1. INDUSTRY OVERVIEW 2. TRENDS, DRIVERS AND ISSUES 3. PRODUCT OVERVIEW 4. PRODUCT INNOVATIONS/INTRODUCTIONS 5. RECENT INDUSTRY ACTIVITY 6. FOCUS ON SELECT GLOBAL PLAYERS 7. GLOBAL MARKET PERSPECTIVE Total Companies Profiled: 219 (including Divisions/Subsidiaries 237) - The United States (130) - Canada (6) - Japan (5) - Europe (52) - - France (7) - - Germany (2) - - The United Kingdom (32) - - Rest of Europe (11) - Asia-Pacific (Excluding Japan) (33) - Latin America (6) - Africa (5) For more information visit http://www.researchandmarkets.com/research/4fbw8q/sports_and
KO: 41.50 (+0.45), POST: 44.63 (-0.28), MNST: 132.64 (+2.70), ABT: 48.67 (+1.64), GSK: 44.99 (+0.46), PEP: 98.00 (+1.59)
India Coronary Stent Market to be Tripled by 2021
PR Newswire Europe - Tue May 05, 3:25AM CDT
No one has covered cath labs in India like us: ABMRG
BSX: 17.91 (+0.68), ABT: 48.67 (+1.64), MDT: 76.26 (+1.40)
Can Mylan (MYL) Specialty Segment Secure Earnings Beat? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon May 04, 3:00PM CDT
Mylan (MYL) is set to report first-quarter 2015 results on May 5 after market closes.
ABT: 48.67 (+1.64), ACT: 297.46 (+1.77), PRGO: 194.15 (+0.36), MYL: 71.53 (+0.68)
